Skip to content

Clinical trials

Hypertension, Pulmonary trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: South Korea Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20061
20071
20081
20094
20105
20122
20131
20161
20171
20192
20201
20212
20221
20231
20241
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting5
Active, not recruiting4
Terminated3
Unknown status3
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Novartis Pharmaceuticals4
Actelion3
Seoul National University Hospital3
United Therapeutics3
Insmed Incorporated2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Asan Medical Center1
Gachon University Gil Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary34
Pulmonary Arterial Hypertension13
Lung Diseases, Interstitial4
Cardiovascular Diseases3
Lung Diseases3
Vascular Diseases3
Connective Tissue Diseases2
Dyspnea2
Familial Primary Pulmonary Hypertension2
Hypertension2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.